Actively Recruiting

Age: 18Years +
All Genders
ID06922526

Predictors of Tricuspid Regurgitation Progression and Adverse Outcomes in Different Pacing Modes

Led by Haiyan Wang · Updated on 2025-04-30

200

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying tricuspid regurgitation (TR), a common complication after implantation of cardiac implantable electronic devices (CIEDs) like pacemakers. Severe TR is linked to higher risks of heart failure hospitalization and death, greatly affecting quality of life. This observational study aims to identify factors predicting worsening TR and adverse outcomes in patients with different pacing methods, to guide care for those at high risk. The study reviews patients who had pacemaker implantation between 2015 and 2025, categorized by pacing type: right ventricular, conduction system, or biventricular pacing. It analyzes TR progression defined as an increase of at least half a grade. Assessments include 3D echocardiography to understand TR mechanisms, fluoroscopic analysis of pacemaker leads, and evaluation of device-related complications like lead dislodgement or infection, along with heart failure readmissions. Participants' data from up to one year of follow-up will be analyzed to measure TR progression and heart failure hospitalizations. The research includes clinical evaluations, imaging studies, and device parameter measurements. This approach helps monitor how pacing modes affect TR and outcomes, aiming to improve management strategies for patients with implanted cardiac devices.

CONDITIONS

Brief Title

Pacemaker-related Tricuspid Regurgitation Progression and Long-term Outcomes

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients
  • Patients with an implantable electronic heart device (CIEDs)
  • Patients who underwent pacemaker implantation at Qianfoshan Hospital between 2015 and 2025
Not Eligible

You will not qualify if you...

  • Patients with severe tricuspid regurgitation or prior tricuspid valve surgery or interventional treatment before pacemaker implantation
  • Patients with severe valvular heart disease, congenital heart disease, or arrhythmias
  • Patients with single-chamber pacemakers or poor imaging quality

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Procedure day

Participants undergo pacemaker implantation using one of the pacing methods: right ventricular pacing, conduction system pacing, or biventricular pacing.

1 visit (in-person)

Long-term Monitoring

Duration - Mean follow-up of 1 year

Participants are observed over time to assess tricuspid regurgitation progression and clinical outcomes including heart failure readmission and device-related complications.

Regular follow-up visits during the year as per clinical care

Trial Site Locations

Total: 1 location

1

The First Affiliated Hospital of Shandong First Medical University

Jinan, China, 250000

Actively Recruiting

Loading map...

Research Team

H

Haiyan Wang, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

5

Similar Trials

Definition and Prognosis of Atrioventricular Regurgitation i...

ATTR Amyloidosis With Cardiomyopathy

Actively Recruiting

8 locations

Annuloplasty Rings and Band Post-Market Clinical Follow-Up (...

Mitral Regurgitation

Actively Recruiting

17 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Tricuspid regurgitation following pacemaker implantation for bradycardia: a two-year study comparing different pacing strategies.

Xiaofei Li, Xiaohan Fan, Qian Wang...

https://pubmed.ncbi.nlm.nih.gov/37649400